Sibanye Stillwater enters the final week of September with a striking divergence between its lending market and its peer group — the borrow cost surged more than fourfold in a month while JSE stablemates trade in different directions entirely.
The most dramatic signal of the week sits in the borrow market. Cost to borrow more than tripled over the past month, rising from below 1% in late August to a peak near 6.5% on September 18, before easing to 3.3% by Tuesday. That kind of volatility in borrowing costs — oscillating between sub-1% and 6.5% within a matter of weeks — reflects episodic bursts of fresh demand for shorts rather than a steady structural build. Availability has tightened sharply alongside this move: it compressed from a loose 365% in early September to a tight 72% mid-week before recovering to roughly 105% by Tuesday. That recovery in availability suggests some of the borrow demand has eased, but the lending pool remains far tighter than it was a month ago. The ORTEX short score has climbed from 50 to 58 over the past two weeks, stopping short of extreme territory but marking a clear directional shift since early September.
Where positioning diverges is in the broader peer story. IMP fell nearly 10% on Tuesday alone and is down almost 12% on the week — a sharper move than Sibanye's own 5% weekly decline. dropped 6.7% on the week. Meanwhile, on the TSX and on the LSE each gained 4-5% over the same period. That split — JSE-listed PGM and precious metals names selling off while London and Toronto peers hold up — points to a local South African market dynamic as much as a commodity-price one. Sibanye, at ZAR 45.11, is down 10% over the past month and sitting closer to its lows than its cross-listed peers.
The institutional picture shows concentrated, mostly passive ownership. State Street holds 27.6% of shares, with Public Investment Corporation holding a further 17%. Among more active names, JPMorgan trimmed its position by 16 million shares as of June 30, while Arrowstreet cut by 11 million over the same period. Mirae Asset moved the other way, adding 21 million shares. The insider register is unambiguously constructive: every recorded transaction in the past year except one is a buy. CFO Charl Keyter purchased 200,000 shares in June and 183,000 in March, totalling over ZAR 16 million across those two clusters. The net insider flow over the past 90 days reached approximately ZAR 7.9 million. The single sale on record — from a technical officer last September at ZAR 45.67 — happened almost exactly at the current price level.
Valuation is cheap in absolute terms. The stock trades at a PE of 4.4x, a price-to-book of 1.96x, and an EV/EBITDA of 2.8x. Forward earnings are expected to grow sharply — the eps_12m_fwd_yoy_increase factor scores in the 82nd percentile — but the quality picture remains weak, and the dividend has not been paid since March 2022, removing a key support for income-oriented holders. Analyst data on file is over five years old and cannot be used to frame a price-target view. The forward earnings recovery story is what the bulls hold; the bears point to balance sheet concerns, the absence of dividends, and the persistent short-score creep.
Next results are scheduled for November 13. Between now and then, the key variable to watch is whether the borrow market tightens again — another compression below 80% availability alongside a short score pushing toward 65 would represent a more charged setup heading into that print.
See the live data behind this article on ORTEX.
Open SSW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
